amfenac has been researched along with Dry Eye Syndromes in 1 studies
amfenac: RN given refers to parent cpd; structure
amfenac : An oxo monocarboxylic acid that is benzophenone in which one of the phenyl groups is substituted by an amino group and a carboxymethyl group at position 2 and 3, respectively. The corresponding carboxamide, nepafenac, is a prodrug of amfenac and is used for the treatment of pain and inflammation following cataract surgery.
Dry Eye Syndromes: Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have developed a rapid and straightforward topical treatment method for dry eye disease (DED) using poly(catechin) capped-gold nanoparticles (Au@Poly-CH NPs) carrying amfenac [AF; a nonsteroidal anti-inflammatory drug (NSAID)] through effective attenuation of ocular surface tissue damage in dry eyes." | 3.91 | Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease. ( Chang, HT; Harroun, SG; Huang, CC; Huang, YF; Lai, JY; Li, YJ; Luo, LJ; Unnikrishnan, B; Wei, SC, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, YJ | 1 |
| Luo, LJ | 1 |
| Harroun, SG | 1 |
| Wei, SC | 1 |
| Unnikrishnan, B | 1 |
| Chang, HT | 1 |
| Huang, YF | 1 |
| Lai, JY | 1 |
| Huang, CC | 1 |
1 other study available for amfenac and Dry Eye Syndromes
| Article | Year |
|---|---|
Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biocompatible Materials; Catechin; Cell Line; Corne | 2019 |